These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3729722)

  • 1. The existence of an envelope on extracellular cowpox virus and its antigenic relationship to the vaccinia envelope.
    Payne LG
    Arch Virol; 1986; 90(1-2):125-33. PubMed ID: 3729722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
    Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the antigens present on the surface of virus released artificially from chick cells infected with vaccinia virus, and cowpox virus and its white pock mutant.
    Baxby D
    J Hyg (Lond); 1972 Jun; 70(2):353-65. PubMed ID: 4624399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
    Law M; Smith GL
    Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs.
    López N; Scolaro L; Rossi C; Jácamo R; Candurra N; Pujol C; Damonte EB; Franze-Fernández MT
    J Gen Virol; 2000 May; 81(Pt 5):1273-81. PubMed ID: 10769070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
    Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
    J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on LS antigens induced by vaccinia and cowpox viruses.
    Ikuta K; Miyamoto H; Kato S
    J Gen Virol; 1979 Dec; 45(3):755-9. PubMed ID: 94351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope detection in the envelope of intracellular naked orthopox viruses and identification of encoding genes.
    Czerny CP; Johann S; Hölzle L; Meyer H
    Virology; 1994 May; 200(2):764-77. PubMed ID: 7513922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain.
    Spehner D; Drillien R; Proamer F; Houssais-Pêcheur C; Zanta MA; Geist M; Dott K; Balloul JM
    Virology; 2000 Jul; 273(1):9-15. PubMed ID: 10891402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.
    Payne LG
    J Gen Virol; 1980 Sep; 50(1):89-100. PubMed ID: 7441216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
    Engelstad M; Smith GL
    Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologically cross-reactive polypeptides in vaccinia, cowpox and Shope fibroma viruses.
    Ikuta K; Miyamoto H; Kato S
    J Gen Virol; 1979 Aug; 44(2):557-63. PubMed ID: 230296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organization of the vaccinia envelope and relationship to the structure of intracellular mature virions.
    Wilton S; Mohandas AR; Dales S
    Virology; 1995 Dec; 214(2):503-11. PubMed ID: 8553552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
    Jones-Trower A; Garcia A; Meseda CA; He Y; Weiss C; Kumar A; Weir JP; Merchlinsky M
    Virology; 2005 Dec; 343(1):128-40. PubMed ID: 16165184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and location of the major glycoprotein of vaccinia virus.
    Boisvert J; Yamamoto T
    Microbios; 1976; 16(63):55-72. PubMed ID: 1026850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies.
    Czerny CP; Mahnel H
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2341-52. PubMed ID: 1700065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relatedness of glycoproteins expressed on the surface of simian herpes-virus virions and infected cells to specific HSV glycoproteins.
    Eberle R; Black D; Hilliard JK
    Arch Virol; 1989; 109(3-4):233-52. PubMed ID: 2482016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope.
    Gordon J; Mohandas A; Wilton S; Dales S
    Virology; 1991 Apr; 181(2):671-86. PubMed ID: 1707568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.